BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37756444)

  • 21. Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and to define their diagnostic roles in current scenario.
    Arora S; Kumar R; Passah A; Tripathi M; Agarwala S; Khadgawat R; Bal C
    Nucl Med Commun; 2019 Dec; 40(12):1230-1242. PubMed ID: 31633647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of 18F-DOPA PET/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas.
    Bacca A; Chiacchio S; Zampa V; Carrara D; Duce V; Congregati C; Simi P; Taddei S; Materazzi G; Volterrani D; Mariani G; Bernini G
    Clin Nucl Med; 2014 Jan; 39(1):14-20. PubMed ID: 24300347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rare case of multiple paragangliomas in the head and neck, retroperitoneum and duodenum: A case report and review of the literature.
    Kawanabe S; Katabami T; Oshima R; Yanagisawa N; Sone M; Kimura N
    Front Endocrinol (Lausanne); 2022; 13():1054468. PubMed ID: 36704041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
    Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS
    Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A
    Amodru V; Romanet P; Scemama U; Montava M; Fakhry N; Sebag F; Castinetti F; Lavieille JP; Loundou A; Varoquaux A; Barlier A; Pacak K; Taïeb D
    Head Neck; 2019 Jun; 41(6):1565-1571. PubMed ID: 30584686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squamous Cell Carcinoma Mimicking Neck Paraganglioma on 68Ga-DOTATATE PET/CT.
    Civan C; Isik EG; Has Simsek D; Sen C; Unal SN
    Clin Nucl Med; 2021 Jul; 46(7):e368-e370. PubMed ID: 33630807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide receptor radionuclide therapy with (90)Y/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours).
    Puranik AD; Kulkarni HR; Singh A; Baum RP
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1223-30. PubMed ID: 25822655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
    Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
    J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.
    Timmers HJ; Gimenez-Roqueplo AP; Mannelli M; Pacak K
    Endocr Relat Cancer; 2009 Jun; 16(2):391-400. PubMed ID: 19190077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of somatostatin receptor imaging in patients with suspected head and neck paragangliomas.
    Schmidt M; Fischer E; Dietlein M; Michel O; Weber K; Moka D; Stennert E; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1571-80. PubMed ID: 12458390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
    Duet M; Sauvaget E; Pételle B; Rizzo N; Guichard JP; Wassef M; Le Cloirec J; Herman P; Tran Ba Huy P
    J Nucl Med; 2003 Nov; 44(11):1767-74. PubMed ID: 14602858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of
    Ma G; Du J; Zhang X; Liu J; Xu X; Xu B; Guan Z
    Quant Imaging Med Surg; 2022 Apr; 12(4):2427-2440. PubMed ID: 35371938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head and Neck Paragangliomas-A Genetic Overview.
    Majewska A; Budny B; Ziemnicka K; Ruchała M; Wierzbicka M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ⁶⁸Ga-DOTA⁰-Tyr³-octreotide positron emission tomography in head and neck squamous cell carcinoma.
    Schartinger VH; Dudás J; Decristoforo C; Url C; Schnabl J; Göbel G; Virgolini IJ; Riechelmann H; Rasse M; Waitz D; Putzer D
    Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1365-72. PubMed ID: 23685751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic utility of Gallium-68-somatostatin receptor PET/CT in ectopic ACTH-secreting tumors: a systematic literature review and single-center clinical experience.
    Varlamov E; Hinojosa-Amaya JM; Stack M; Fleseriu M
    Pituitary; 2019 Oct; 22(5):445-455. PubMed ID: 31236798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma.
    Kong G; Schenberg T; Yates CJ; Trainer A; Sachithanandan N; Iravani A; Ravi Kumar A; Hofman MS; Akhurst T; Michael M; Hicks RJ
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5091-5099. PubMed ID: 30977831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
    King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 131I-MIBG, 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT scans in a patient with extra adrenal paraganglioma associated with SDH-B gene mutation.
    Kasaliwal R; Malhotra G; Lila A; Bandgar T; Shah NS
    Clin Nucl Med; 2015 May; 40(5):439-41. PubMed ID: 25742231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Somatostatin Receptor-Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis.
    Barrio M; Czernin J; Fanti S; Ambrosini V; Binse I; Du L; Eiber M; Herrmann K; Fendler WP
    J Nucl Med; 2017 May; 58(5):756-761. PubMed ID: 28082438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of
    Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
    J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.